Compare KARO & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KARO | PRCT |
|---|---|---|
| Founded | 2001 | 2009 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2020 | 2021 |
| Metric | KARO | PRCT |
|---|---|---|
| Price | $46.75 | $25.96 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 11 |
| Target Price | ★ $59.00 | $35.44 |
| AVG Volume (30 Days) | 35.7K | ★ 2.1M |
| Earning Date | 01-01-0001 | 05-27-2026 |
| Dividend Yield | ★ 2.65% | N/A |
| EPS Growth | N/A | ★ 1.71 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $308,054,000.00 |
| Revenue This Year | $22.17 | $32.85 |
| Revenue Next Year | $16.74 | $24.66 |
| P/E Ratio | $24.13 | ★ N/A |
| Revenue Growth | N/A | ★ 37.22 |
| 52 Week Low | $35.97 | $19.35 |
| 52 Week High | $60.95 | $64.89 |
| Indicator | KARO | PRCT |
|---|---|---|
| Relative Strength Index (RSI) | 48.33 | 46.86 |
| Support Level | $44.43 | $19.35 |
| Resistance Level | $47.92 | $29.24 |
| Average True Range (ATR) | 1.53 | 2.16 |
| MACD | 0.01 | 0.21 |
| Stochastic Oscillator | 66.54 | 72.52 |
Karooooo Ltd is a provider of real-time mobility data analytics solutions for smart transportation. It offers a comprehensive, cloud-based smart mobility platform for connected vehicles and other assets. The company's software-as-a-service platform provides customers with differentiated insights and analytics to optimize business and workforce, increase efficiency and decrease costs, improve safety, monitor environmental impact, assist with regularity compliance, and manage risk. The segments of the group are Cartrack; Carzuka; and Karooooo Logistics, of which key revenue is derived from the Cartrack segment.
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.